- Home
- LSAK vs EBS Comparison
LSAK vs EBS Comparison
Compare LSAK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- EBS
- Stock Information
- Founded
- LSAK 1997
- EBS 1998
- Country
- LSAK South Africa
- EBS United States
- Employees
- LSAK N/A
- EBS N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- EBS Health Care
- Exchange
- LSAK Nasdaq
- EBS Nasdaq
- Market Cap
- LSAK 408.0M
- EBS 393.9M
- IPO Year
- LSAK N/A
- EBS 2006
- Fundamental
- Price
- LSAK $5.00
- EBS $4.74
- Analyst Decision
- LSAK
- EBS Strong Buy
- Analyst Count
- LSAK 0
- EBS 3
- Target Price
- LSAK N/A
- EBS $14.33
- AVG Volume (30 Days)
- LSAK 33.5K
- EBS 1.2M
- Earning Date
- LSAK 05-07-2025
- EBS 04-30-2025
- Dividend Yield
- LSAK N/A
- EBS N/A
- EPS Growth
- LSAK N/A
- EBS N/A
- EPS
- LSAK N/A
- EBS N/A
- Revenue
- LSAK $576,604,000.00
- EBS $1,043,600,000.00
- Revenue This Year
- LSAK $0.04
- EBS N/A
- Revenue Next Year
- LSAK $1.74
- EBS $19.88
- P/E Ratio
- LSAK N/A
- EBS N/A
- Revenue Growth
- LSAK 5.39
- EBS N/A
- 52 Week Low
- LSAK $3.83
- EBS $1.82
- 52 Week High
- LSAK $5.60
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- LSAK 56.02
- EBS 27.59
- Support Level
- LSAK $4.51
- EBS $4.53
- Resistance Level
- LSAK $5.10
- EBS $5.46
- Average True Range (ATR)
- LSAK 0.26
- EBS 0.38
- MACD
- LSAK 0.04
- EBS 0.03
- Stochastic Oscillator
- LSAK 86.67
- EBS 12.35
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.